Neo Ivy Capital Management Repligen Corp Transaction History
Neo Ivy Capital Management
- $505 Million
- Q2 2024
A detailed history of Neo Ivy Capital Management transactions in Repligen Corp stock. As of the latest transaction made, Neo Ivy Capital Management holds 23,148 shares of RGEN stock, worth $3.16 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
23,148
Previous 912
2438.16%
Holding current value
$3.16 Million
Previous $164,000
1679.27%
% of portfolio
0.58%
Previous 0.37%
Shares
12 transactions
Others Institutions Holding RGEN
# of Institutions
496Shares Held
53.9MCall Options Held
420KPut Options Held
85.3K-
Black Rock Inc. New York, NY7.57MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.07MShares$693 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.61MShares$630 Million0.07% of portfolio
-
State Street Corp Boston, MA1.74MShares$238 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA1.42MShares$194 Million0.55% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.59B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....